Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application

Area of Science:

• Neuroscience
• Biomedical Engineering
• Gerontology

Background:

• Alzheimer's disease (AD) and dementia prevalence are projected to double in 30 years.
• A gap exists between basic science research and clinical application of novel therapeutics.
• Photobiomodulation therapy (PBT) offers a potential novel approach for AD prevention and treatment.

Purpose of the Study:

• To review the literature on PBT for Alzheimer's disease.
• To consolidate treatment parameters for PBT in AD.
• To bridge the gap between basic research and clinical practice for PBT in AD.

Main Methods:

• Literature review of photobiomodulation therapy studies related to Alzheimer's disease.
• Analysis of cellular mechanisms of PBT against AD pathology.
• Examination of safety and efficacy data from cell culture, animal models, and human case studies.

Main Results:

• PBT demonstrates promising results in preclinical cell culture and animal models of AD.
• Mechanistic studies reveal PBT's action at the cellular level against AD.
• Early human case studies suggest safety and efficacy, warranting further investigation.

Conclusions:

• PBT is a safe and potentially effective therapeutic strategy for Alzheimer's disease.
• Established safe and effective doses in animal models provide a basis for clinical trials.
• Further large-scale clinical trials are recommended to translate PBT from bench to bedside for AD treatment.